- Use of JAK inhibitors in rheumatoid arthritis
- Psoriatic arthritis
- Gynecological and obstetric care of patients with Sjogren’s syndrome
- Nonsteroidal anti-inflammatory drugs in axial spondyloarthritis
- Direct oral anticoagulants in antiphospholipid syndrome
- Axial spondyloarthritis: clinical management
- Diagnosis of Sjögren’s syndrome: glandular manifestations
- Investigation and diagnosis of systemic autoimmune myopathies
[featured article] Guidelines on COVID-19 vaccination in patients with immune-mediated rheumatic diseases
A task force was constituted by 24 rheumatologists (panel members), with clinical and research expertise in immunizations and infectious diseases in immunocompromised patients, endorsed by the Brazilian Society of Rheumatology (BSR), to develop guidelines for COVID-19 vaccination in patients with immune-mediated rheumatic diseases. Read more.
-
-
A brazilian nationwide multicenter study on deficiency of deaminase-2 (DADA2)
-
Crosstalk between the JAK2 and TGF-β1 signaling pathways in scleroderma-related interstitial lung disease targeted by baricitinib
-
Anti-SSA/SSB-negative primary Sjögren’s syndrome showing different clinical phenotypes: a retrospective study of 934 cases
-
Comparison of clinical features, disease activity, treatment and outcomes between late-onset and early-onset patients with systemic lupus erythematosus. A sex- and year at diagnosis-matched controlled study
-
XXXV Brazilian Congress of Rheumatology (SBR 2018)
-
Comparing the efficacy and safety of duloxetine and amitriptyline in the treatment of fibromyalgia: overview of systematic reviews
-
Panniculitides of particular interest to the rheumatologist
-
Ultrasound and its clinical use in rheumatoid arthritis: where do we stand?
-
A systematic review of the effects of strength training in patients with fibromyalgia: clinical outcomes and design considerations
Guideline Collection
Preprint sharing
We encourage archiving of primary research manuscripts on preprint servers, authors’ or institutional websites. Read more on preprint sharing and citation.
Journal archives
Formerly named Revista Brasileira de Reumatologia, the journal is celebrating its 60th year of publication in 2020. Articles published prior to January 2018 are available here.
Celebrating Rare Diseases Month: Rare, but Frequently Seen by Rheumatologists
Guest Editor:
Dr. Sandro Félix Perazzio: Federal University of Sao Paulo, Brazil
Submission Status: Open until 15 January 2024
Aims and scope
Advances in Rheumatology is an international, open access journal publishing pre-clinical, translational and clinical studies on all aspects of paediatric and adult rheumatic diseases, including degenerative, inflammatory and autoimmune conditions. We welcome original research (including systematic reviews and meta-analyses), reviews, guidelines and letters arising from published material.
About the Editors-in-Chief
Dr. Marcos Renato de Assis is Professor of Rheumatology at Marilia Medical School, Brazil. He completed his PhD in Rehabilitation at Federal University of São Paulo, in 2003, studying patients with fibromyalgia. He also has specialization in PM&R and acted as senior teaching assistant for a distance-learning training program on clinical research by Harvard Medical School (2010-2015). His interests are fibromyalgia, rheumatoid arthritis, spondyloarthritis, tools validation and distance learning.
Dr. Eduardo dos Santos Paiva is Professor of Rheumatology in the Universidade Federal do Parana, in Curitiba, Brazil. He received his PhD in Internal Medicine from the same University, studying patients with fibromyalgia and obesity. He was a fellow in the Division of Arthritis and Rheumatic Diseases in the Oregon Health and Sciences University. He is a Fellow of the American College of Rheumatology. His areas of interest are fibromyalgia, pain rheumatic diseases, musculoskeletal ultrasound, and multiprofessional care for patients with rheumatic and musculoskeletal diseases.
About the Society
The Brazilian Society of Rheumatology (SBR) was founded in 1949 and its mission is to promote excellence in rheumatology by encouraging teaching, research and care, and contributing to the formulation of public policies aimed at the health and well-being of the rheumatic patients. SBR brings together Brazilian rheumatologists, disseminating the specialty, organizing courses and congresses, and fostering scientific research.
In 2018, the Society approved and published its Code of Ethics whose principles are intended to ensure its mission, vision, and values, according to its statuses and bylaws. Read the full document here.
Official journal of
Annual Journal Metrics
-
Citation Impact
3.010 - 2-year Impact Factor (2021)
3.123 - 5-year Impact Factor (2021)
3.3 - CiteScore
1.094 - Source Normalized Impact per Paper (SNIP)
0.669 - SCImago Journal Rank (SJR)Speed
40 days to first decision for all manuscripts (Median)
58 days to first decision for reviewed manuscripts only (Median)Usage
438,408 Downloads (2021)
117 Altmetric mentions (2021)